ArticleJournal of clinical practice and research2026
Comparison of Success Rates Between Laser Photocoagulation and Intravitreal Anti-Vascular Endothelial Growth Factor Injection for the Treatment of Retinopathy of Prematurity in a Tertiary Referral Center: An 11-Year Survey.
Article in Journal of clinical practice and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the success and reactivation rates between laser photocoagulation and intravitreal anti-VEGF injection for the treatment of retinopathy of prematurity (ROP). Materials and Methods: A total of 434 patients with ROP were included in the study, with 299 treated with laser photocoagulation (group 1) and 135 treated with intravitreal anti-VEGF injection (group 2). Outcome measures included birth weight, gestational age, disease stage, presence of plus disease, type of first intervention, time of postpartum ROP onset, date and time of recurrence after the first intervention, type of second intervention following recurrence, and sex. Results: Laser photocoagulation (LP) was performed in 299 premature patients, and intravitreal anti-VEGF injection was the first intervention in 135 patients. The overall reactivation rate for ROP after treatment was 6.5% (n=28). The reactivation rates for group 1 and group 2 were 3.7% (n=11) and 12.6% (n=17), respectively, with the difference being significant (p<0.001). Over the past 11 years, there has been a shift from laser treatment to anti-VEGF therapy, with anti-VEGF therapy linked to a 3.77-fold higher risk of reactivation. Low birth weight, low gestational age, and aggressive posterior ROP were identified as factors contributing to an elevated risk of reactivation. The median time to reactivation was similar for both group 1 and group 2 patients (p>0.05). Conclusion: Both laser application and anti-VEGF injection were effective for the treatment of ROP. However, initial LP has a lower reactivation rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.